1. |
Volkman R, Offen D. Concise review: mesenchymal stem cells in neurodegenerative diseases. Stem Cells, 2017, 35(8): 1867-1880.
|
2. |
郑伟伟, 杨民, 武成, 等. 滑膜间充质干细胞体内外成骨特性的实验研究. 中国修复重建外科杂志, 2016, 30(1): 102-109.
|
3. |
de Souza LE, Malta TM, Kashima Haddad S, et al. Mesenchymal stem cells and pericytes: to what extent are they related? Stem Cells Dev, 2016, 25(24): 1843-1852.
|
4. |
Gazdic M, Arsenijevic A, Markovic BS, et al. Mesenchymal stem cell-dependent modulation of liver diseases. Int J Biol Sci, 2017, 13(9): 1109-1117.
|
5. |
Barakat M, Gabr MM, Zhran F, et al. Upregulation of heme oxygenase 1 (HO-1) attenuates kidney damage, oxidative stress and inflammatory reaction during renal ischemia/reperfusion injury. Gen Physiol Biophys, 2018, 37(2): 193-204.
|
6. |
Agarwal A, Nick HS. Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol, 2000, 11(5): 965-973.
|
7. |
Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci, 2016, 73(17): 3221-3247.
|
8. |
Lin R, Cai J, Kostuk EW, et al. Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats. J Neuroinflammation, 2016, 13(1): 269.
|
9. |
Tomczyk M, Kraszewska I, Dulak J, et al. Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1. Vascul Pharmacol, 2019, 112: 79-90.
|
10. |
Even B, Fayad-Kobeissi S, Gagliolo JM, et al. Heme oxygenase-1 induction attenuates senescence in chronic obstructive pulmonary disease lung fibroblasts by protecting against mitochondria dysfunction. Aging Cell, 2018, 17(6): e12837.
|
11. |
Jun SY, Hong SM, Bae YK, et al. Clinicopathological and prognostic significance of heme oxygenase-1 expression in small intestinal adenocarcinomas. Pathol Int, 2018, 68(5): 294-300.
|
12. |
葛礼豪, 于德水, 苏瑞超, 等. 缺氧诱导因子 1α 对人羊膜间充质干细胞耐受缺氧能力影响的实验研究. 中国修复重建外科杂志, 2018, 32(3): 264-269.
|
13. |
Liu N, Wang H, Han G, et al. Alleviation of apoptosis of bone marrow-derived mesenchymal stem cells in the acute injured kidney by heme oxygenase-1 gene modification. Int J Biochem Cell Biol, 2015, 69: 85-94.
|
14. |
Cremers NA, Lundvig DM, van Dalen SC, et al. Curcumin-induced heme oxygenase-1 expression prevents H2O2-induced cell death in wild type and heme oxygenase-2 knockout adipose-derived mesenchymal stem cells. Int J Mol Sci, 2014, 15(10): 17974-17999.
|
15. |
Patel SR, Copland IB, Garcia MA, et al. Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1. Cytotherapy, 2015, 17(4): 382-391.
|
16. |
Deramaudt TB, da Silva JL, Remy P, et al. Negative regulation of human heme oxygenase in microvessel endothelial cells by dexamethasone. Proc Soc Exp Biol Med, 1999, 222(2): 185-193.
|
17. |
Wang X, Wang S, Zhou Y, et al. BM-MSCs protect against liver ischemia/reperfusion injury via HO-1 mediated autophagy. Mol Med Rep, 2018, 18(2): 2253-2262.
|
18. |
Hamedi-Asl P, Halabian R, Bahmani P, et al. Adenovirus-mediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses. Cell Stress Chaperones, 2012, 17(2): 181-190.
|
19. |
Yu ZY, Ma D, He ZC, et al. Heme oxygenase-1 protects bone marrow mesenchymal stem cells from iron overload through decreasing reactive oxygen species and promoting IL-10 generation. Exp Cell Res, 2018, 362(1): 28-42.
|
20. |
Tang YL, Tang Y, Zhang YC, et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol, 2005, 46(7): 1339-1350.
|
21. |
Pan H, Guan D, Liu X, et al. SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res, 2016, 26(2): 190-205.
|
22. |
Davis C, Dukes A, Drewry M, et al. MicroRNA-183-5p increases with age in bone-derived extracellular vesicles, suppresses bone marrow stromal (stem) cell proliferation, and induces stem cell senescence. Tissue Eng Part A, 2017, 23(21-22): 1231-1240.
|
23. |
Barbagallo I, Vanella A, Peterson SJ, et al. Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. J Bone Miner Metab, 2010, 28(3): 276-288.
|
24. |
Vanella L, Kim DH, Asprinio D, et al. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone, 2010, 46(1): 236-243.
|
25. |
Gu Q, Gu Y, Shi Q, et al. Hypoxia promotes osteogenesis of human placental-derived mesenchymal stem cells. Tohoku J Exp Med, 2016, 239(4): 287-296.
|
26. |
Liu X, Ji C, Xu L, et al. Hmox1 promotes osteogenic differentiation at the expense of reduced adipogenic differentiation induced by BMP9 in C3H10T1/2 cells. J Cell Biochem, 2018, 119(7): 5503-5516.
|
27. |
Shen ZY, Wu B, Liu T, et al. Immunomodulatory effects of bone marrow mesenchymal stem cells overexpressing heme oxygenase-1: Protective effects on acute rejection following reduced-size liver transplantation in a rat model. Cell Immunol, 2017, 313: 10-24.
|
28. |
Zhang D, Fu L, Wang L, et al. Therapeutic benefit of mesenchymal stem cells in pregnant rats with angiotensin receptor agonistic autoantibody-induced hypertension: Implications for immunomodulation and cytoprotection. Hypertens Pregnancy, 2017, 36(3): 247-258.
|
29. |
Suresh SC, Selvaraju V, Thirunavukkarasu M, et al. Thioredoxin-1(Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium. Int J Cardiol, 2015, 201: 517-528.
|
30. |
Shu T, Zeng B, Ren X, et al. HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium. Tissue Cell, 2010, 42(4): 217-222.
|
31. |
Wang J, Hu X, Jiang H. MSCs modified with HO-1 gene transplantation: A novel therapeutic approach for attenuating heart failure. Int J Cardiol, 2016, 214: 159-160.
|
32. |
Zhang ZH, Zhu W, Ren HZ, et al. Mesenchymal stem cells increase expression of heme oxygenase-1 leading to anti-inflammatory activity in treatment of acute liver failure. Stem Cell Res Ther, 2017, 8(1): 70.
|
33. |
Chen X, Zhang Y, Wang W, et al. Mesenchymal stem cells modified with Heme oxygenase-1 have enhanced paracrine function and attenuate lipopolysaccharide-induced inflammatory and oxidative damage in pulmonary microvascular endothelial cells. Cell Physiol Biochem, 2018, 49(1): 101-122.
|
34. |
Liu N, Wang H, Han G, et al. Enhanced proliferation and differentiation of HO-1 gene-modified bone marrow-derived mesenchymal stem cells in the acute injured kidney. Int J Mol Med, 2018, 42(2): 946-956.
|
35. |
王绕绕, 宋红丽. 自噬在肝移植缺血再灌注损伤中的研究进展. 中华器官移植杂志, 2015, 36(9): 565-568.
|
36. |
Wang Y, Wang JL, Ma HC, et al. Mesenchymal stem cells increase heme oxygenase 1-activated autophagy in treatment of acute liver failure. Biochem Biophys Res Commun, 2019, 508(3): 682-689.
|
37. |
Wang R, Shen Z, Yang L, et al. Protective effects of heme oxygenase-1-transduced bone marrow-derived mesenchymal stem cells on reduced-size liver transplantation: Role of autophagy regulated by the ERK/mTOR signaling pathway. Int J Mol Med, 2017, 40(5): 1537-1548.
|
38. |
Yu M, Wang J, Fang Q, et al. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg. Transpl Immunol, 2016, 37: 10-17.
|
39. |
Lee HS, Song S, Shin DY, et al. Enhanced effect of human mesenchymal stem cells expressing human TNF-αR-Fc and HO-1 gene on porcine islet xenotransplantation in humanized mice. Xenotransplantation, 2018, 25(1). doi: 10.1111/xen.12342.
|
40. |
Wu B, Song HL, Yang Y, et al. Improvement of liver transplantation outcome by Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in rats. Stem Cells Int, 2016, 2016: 9235073.
|
41. |
Yang L, Shen ZY, Wang RR, et al. Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation. World J Gastroenterol, 2017, 23(19): 3449-3467.
|
42. |
Yang Y, Song HL, Zhang W, et al. Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats. Stem Cell Res Ther, 2016, 7(1): 164.
|
43. |
Yin ML, Song HL, Yang Y, et al. Effect of CXCR3/HO-1 genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection. World J Gastroenterol, 2017, 23(22): 4016-4038.
|
44. |
Lee SH, Kim Y, Rhew D, et al. Effect of canine mesenchymal stromal cells overexpressing heme oxygenase-1 in spinal cord injury. J Vet Sci, 2017, 18(3): 377-386.
|
45. |
Hou C, Shen L, Huang Q, et al. The effect of heme oxygenase-1 complexed with collagen on MSC performance in the treatment of diabetic ischemic ulcer. Biomaterials, 2013, 34(1): 112-120.
|